DORAL, Florida, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the
“Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical
devices, and research and development, today shares it has started formulating a full spectrum CBD beverage utilizing its
University of Central Oklahoma Provisional Patent to improve immune system functions.
To stay innovative in the CBD industrial the Company is always looking for new ways to deliver its effective
cannabinoids to the public and continue positively change individuals lives. While the Company continues to perfect its CBD nutraceutical provisional patent products, they have also started to formulate a beverage
utilizing its University of Central Oklahoma provisional patent with the help of Dr. Aube, his advisory team
and the Company’s current manufacture near its headquarters.
The new High Grade Full Spectrum Cannabinoids beverage (the CBD beverage) will be focused on immunity due to its
positive results with the Company’s collaboration with the University of Central Oklahoma during
2015. The company is currently working on the CBD beverage formula and looking into different bottling options with its current
manufacture. The CBD beverage will allow the Company to tap into the predicted $11.7 billion this year and grow $25 billion in
seven year cannabis beverage market.
Michel Aube, ETST’s CEO & CSO comments,”The CBD beverage is a most in the époque of legalization of recreative
marijuana. Not only does CBD have positive effects on immune cells, it has strong antioxidant and anti-psychotic properties.
Indeed, it is now well recognized that CBD is an anti psychotic molecule and that CBD has opposite effect to
?-9-tétrahydrocannabinol (THC). This is why health professions are concerned by the fact that most marijuana plants have very low
concentration of CBD and huge amount of THC molecule. At Earth Science Tech we focused on full spectrum cannabinoids derived from
industrial hemp that contains extremely low to no THC since THC is psychoactive causing dependency and mental illness in young
individuals. This means that all our products are beneficial for recreational marijuana consumer because it helps them to balance
their intake of psychoactive and anti-psychotic cannabinoids. Our cannabinoid products help to counter the side effects of THC in
addition of having itself other interesting biological activities like anti-inflammatory and antioxidant properties.”
ETST president, director, and Chairman Nickolas S. Tabraue stated, “This a great opportunity for us while the
cannabis beverage market is in the emerging stage and forecast to grow exponentially. I look forward on sharing updates as we
progress with our new CBD beverage product”.
About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market.
There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to
studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with
positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its
studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.com
ETST currently has four wholly owned subsidiaries focused on developing its role as a world leader in the CBD
space and expanding its work in the pharmaceutical and medical device sectors::
Earth Science Pharmaceutical, Inc.
Earth Science Pharmaceutical ("ESP") is a wholly owned subsidiary of Earth Science Tech), committed to the development of low cost,
noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases.
ESP's CEO and chief science officer, Dr. Michel Aubé, is leading the company’s research and development efforts. The company’s
first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained
gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of
women. To learn more please visit: www.EarthSciencePharmaceutical.com
Cannabis Therapeutics, Inc.
Cannabis Therapeutics (“CTI”) is a wholly owned subsidiary of Earth Science TechTich i poised to take a leadership role in the
development of new, leading-edge cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and
development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for
a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based
pharmaceutical drugs. To learn more please visit: www.CannabisThera.com
KannaBidioiD, Inc.
KannaBidioiD (“KBD”) is a wholly owned subsidiary of Earth Science TechB that provides a wide variety of products geared toward the
recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused vapes/e-liquids
products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus
and the added benefit of assisting with nicotine reduction therapy. To learn more please visit: www.KannaBidioiDInc.com
Earth Science Foundation, Inc.
Earth Science Foundation. (“ESF”) is a wholly owned subsidiary of Earth Science Tech. ESF is in the process of becoming a nonprofit
organization to accept grants and donations to conduct further studies and help donate Earth Science Tech's effective CBD products
to those in need. To learn more please visit: www.ETSTFoundtion.org
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act
of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial
position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions,
growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if,"
"believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are
forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may
cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We
are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether
as a result of new information, future events or otherwise.
Company Contact: www.EarthScienceTech.com Nickolas S. Tabraue President, Director & Chairman 305.615.2118 Office Corporate Communications Contact: NetworkNewsWire (NNW) New York, New York www.NetworkNewsWire.com 212.418.1217 Office Editor@NetworkNewsWire.com
